Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised, ...
MISSISSAUGA, ON, Sept. 30, 2019 /CNW/ - AstraZeneca Canada announced today that Health Canada has approved the expanded use of Symbicort ® Turbuhaler ® (budesonide ...
This randomised, double-blind, double-dummy crossover study was designed to compare the pharmacokinetic profile and pulmonary bioavailability of budesonide 1000µg delivered by inhalation as a powder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results